Reported about 22 hours ago
10x Genomics has announced a global settlement with Bruker Corporation that resolves all patent litigation between the two companies. Under the agreement, Bruker will pay 10x Genomics $68 million in installments from Q3 2025 to Q2 2026, along with ongoing royalties on spatial biology products. The settlement includes patent cross-licenses and the resolution of all legal actions in the US, Germany, and the European Unified Patent Court, emphasizing the importance of intellectual property in fostering scientific innovation.
Source: YAHOO